These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6954617)

  • 21. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of combined treatment on T- and B-lymphocyte activity in tumors of the maxillofacial region of varying histological character].
    Arsanov AA
    Stomatologiia (Mosk); 1979; 58(4):37-9. PubMed ID: 314693
    [No Abstract]   [Full Text] [Related]  

  • 23. [Selection of therapy in precanceroses and malignomas in the maxillofacial region: surgery, radiotherapy, chemotherapy immunotherapy?].
    Sailer HF
    SSO Schweiz Monatsschr Zahnheilkd; 1977 Dec; 87(12):1181-96. PubMed ID: 74093
    [No Abstract]   [Full Text] [Related]  

  • 24. [The characterization of semirigid coaxial antennae for interstitial and endocavitary microwave hyperthermia].
    Erb J; Klautke G; Seegenschmiedt HM; Engelbrecht R; Schaller G; Sauer R
    Strahlenther Onkol; 1994 Nov; 170(11):654-64. PubMed ID: 7974181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theoretical investigation of measurement procedures for the quality assurance of superficial hyperthermia applicators.
    Samaras T; van Rhoon GC; Sahalos JN
    Int J Hyperthermia; 2002; 18(5):416-25. PubMed ID: 12227928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators.
    Cho C; Wust P; Hildebrandt B; Issels RD; Sehouli J; Kerner T; Deja M; Budach V; Gellermann J
    Int J Hyperthermia; 2008 Aug; 24(5):399-408. PubMed ID: 18608591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodology for applied 4 MHz RF hyperthermia concomitant with 31P NMR spectroscopic monitoring of murine tumours.
    Bezabeh T; Evelhoch JL; Sloop DJ; Ackerman JJ
    Int J Hyperthermia; 2004 Sep; 20(6):637-45. PubMed ID: 15370819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychiatric aspects of the combined therapy of patients with maxillofacial neoplasms].
    Dunaevskiĭ VA; Dunaevskiĭ VV
    Stomatologiia (Mosk); 1983; 62(5):63-6. PubMed ID: 6579765
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary results of interstitial application of 198 Au in the treatment of maxillo-facial tumors].
    Popescu V; Bucur A; Stieber C; Stroescu I; Niculescu M; Bratu V
    Rev Stomatol Chir Maxillofac; 1971; 72(5):549-58. PubMed ID: 5285445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperthermia in combination with radiotherapy].
    van der Zee J; van Rhoon GC; Haveman J; González González D
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):76-80. PubMed ID: 10086108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of CEA determination in squamous cell carcinomas of the maxillofacial area].
    Hardt N; Steinhäuser EW; Bloch B
    Dtsch Zahnarztl Z; 1981 Nov; 36(11):767-70. PubMed ID: 6946922
    [No Abstract]   [Full Text] [Related]  

  • 32. [New developments in oncologic hyperthermia].
    Marchal C
    Cancer Radiother; 2003 Nov; 7 Suppl 1():55s-57s. PubMed ID: 15124545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice.
    Udagawa Y; Nagasawa H; Kiyokawa S
    Anticancer Res; 1999; 19(5B):4125-30. PubMed ID: 10628363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective intra-arterial embolization for therapeutic purposes in tumors of the maxillofacial area].
    Bohutová J; Toman J; Kolár J
    Vestn Rentgenol Radiol; 1981; (3):24-7. PubMed ID: 7023016
    [No Abstract]   [Full Text] [Related]  

  • 35. Waveform diversity based ultrasound system for hyperthermia treatment of breast cancer.
    Guo B; Li J
    IEEE Trans Biomed Eng; 2008 Feb; 55(2 Pt 2):822-6. PubMed ID: 18270027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant tumors of the orofacial region treated in in-patient departments].
    Sípková K; Hájek F
    Cesk Stomatol; 1983 Dec; 83(6):436-41. PubMed ID: 6589079
    [No Abstract]   [Full Text] [Related]  

  • 37. [Design of a marking sheet for the programmed documentation of maxillo-facial neoplasms].
    Pape HD; Scheunemann H
    Dtsch Zahnarztl Z; 1970 Jun; 25(6):664-9. PubMed ID: 5269695
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperthermia and cancer therapy: a review of biomedical engineering contributions and challenges.
    Strohbehn JW; Douple EB
    IEEE Trans Biomed Eng; 1984 Dec; 31(12):779-87. PubMed ID: 6396203
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multidisciplinary approach to maxillofacial angiodysplasia].
    Breviere GM; Devauchelle B; Pertuzon B; Pruvo JP
    Rev Stomatol Chir Maxillofac; 1995; 96(4):215-26. PubMed ID: 7569708
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advances and emphasis in tumor treatment involving the oral, mandibular and facial regions].
    Scheunemann H; Schmidseder R
    Fortschr Kiefer Gesichtschir; 1976; 21():155-8. PubMed ID: 1068033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.